Wealth Shield Partners, LLC Abbott Laboratories Transaction History

Wealth Shield Partners, LLC

$721 Million
Q3 2024

A detailed history of Wealth Shield Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Wealth Shield Partners, LLC holds 2,562 shares of ABT stock, worth $329,088. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,562

Holding current value

$329,088

% of portfolio

0.04%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$100.07 - $118.13 $256,379 - $302,649	2,562 New	2,562 $292,000
Q1 2024 Apr 29, 2024	SELL	$109.52 - $120.96 $73,049 - $80,680	-667 Reduced 25.53%	1,946 $221,000
Q4 2023 Jan 23, 2024	SELL	$90.19 - $110.4 $45,455 - $55,641	-504 Reduced 16.17%	2,613 $287,000
Q3 2023 Oct 25, 2023	BUY	$95.53 - $114.62 $40,886 - $49,057	428 Added 15.92%	3,117 $301,000
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $51,196 - $57,043	-508 Reduced 15.89%	2,689 $293,000
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $71,966 - $84,709	-743 Reduced 18.86%	3,197 $323,000
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $9,506 - $11,152	-100 Reduced 2.48%	3,940 $432,000
Q3 2022 Nov 04, 2022	BUY	$96.76 - $112.03 $7,644 - $8,850	79 Added 1.99%	4,040 $391,000
Q2 2022 Aug 11, 2022	SELL	$102.07 - $123.37 $12,554 - $15,174	-123 Reduced 3.01%	3,961 $430,000
Q1 2022 May 09, 2022	SELL	$114.02 - $139.04 $9,691 - $11,818	-85 Reduced 2.04%	4,084 $483,000
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $208,762 - $255,618	1,807 Added 76.5%	4,169 $587,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $59,963 - $66,336	-514 Reduced 17.87%	2,362 $279,000
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $5,818 - $6,849	55 Added 1.95%	2,876 $333,000
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $40,815 - $48,086	-375 Reduced 11.73%	2,821 $338,000
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $12,390 - $13,501	-118 Reduced 3.56%	3,196 $351,000
Q3 2020 Oct 30, 2020	SELL	$91.64 - $111.29 $10,996 - $13,354	-120 Reduced 3.49%	3,314 $361,000
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $262,941 - $336,532	3,434 New	3,434 $314,000
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $451,298 - $659,922	-7,184 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $111,405 - $124,020	-1,419 Reduced 16.49%	7,184 $624,000
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $68,009 - $73,742	831 Added 10.69%	8,603 $720,000
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $125,280 - $146,115	1,719 Added 28.4%	7,772 $654,000
Q1 2019 May 14, 2019	BUY	$66.22 - $80.06 $55,095 - $66,609	832 Added 15.94%	6,053 $484,000
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $58,413 - $66,174	891 Added 20.58%	5,221 $378,000
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $13,560 - $16,359	-223 Reduced 4.9%	4,330 $318,000
Q2 2018 Aug 02, 2018	BUY	$57.57 - $63.54 $5,757 - $6,354	100 Added 2.25%	4,553 $278,000
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $49,855 - $56,367	-886 Reduced 16.59%	4,453 $267,000
Q4 2017 Apr 18, 2018	BUY	$53.68 - $57.47 $286,597 - $306,832	5,339	5,339 $313,000

Others Institutions Holding ABT

# of Institutions

3,228

Shares Held

1.3B

Call Options Held

8.71M

Put Options Held

8.03M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $225B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Shield Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Shield Partners, LLC with notifications on news.

Account

Wealth Shield Partners, LLC Abbott Laboratories Transaction History